Quantib, which spun out of Erasmus MC, maintains a strong partnership with the Departments of Radiology and Medical Informatics of Erasmus MC and its Biomedical Imaging Group Rotterdam, lead by Wiro Niessen, our CSO. This research group consists of over 40 researchers in the field of medical image analysis and machine learning. Our currently available and future products are partly based on the research performed at Erasmus MC.
In 2018 UMC Utrecht and Quantib set up Quantib-U, a joint venture company focused on deep learning utilizing the extensive expertise and imaging data available at UMC Utrecht. The collaboration, in which both UMC Utrecht and Quantib invested manpower, know-how and capital, will be focused on accelerating the conversion of scientific progress into clinical products. Researchers will be working closely with the QIA research group and UMCU Department of Radiology.
Quantib and IBM Watson Health partnered to help healthcare organisations realize the potential of AI in medical imaging while addressing their changing needs. Delivered and supported by IBM, providers can access Quantib® ND Plus for clinically meaningful insights and improved patient care—all within their existing IT infrastructure and clinical workflows, and assured of data privacy, security and performance.
Quantib is partnering with Intrasense since 2016: Quantib® ND Plus has been developed on Myrian® Studio and is a solution based on the Myrian® Platform. This partnership allows physicians to benefit from all of the unique and advanced Quantib® ND Plus tools within a global, well-known and cutting-edge medical imaging platform.
In 2015 Philips contacted Quantib to collaborate on developing a tool to support and improve their image quality assessments. Through regular discussions and prototyping, Quantib supported Philips by designing and implementing a tool which allows for a very flexible and efficient way of assessing image quality. Quantib continued collaboration with Philips in several European image analysis subsidy projects.
Within STARLIT, Quantib will contribute to the development of novel technologies in radiation oncology to improve the quality of life for cancer survivors by using real-time MRI imaging in order to improve treatment accuracy and minimize healthy tissue doses. Under STARLIT Elekta and Philips will work together with six SMEs, providing unique technical capabilities, representing the end customer’s perspective.
Under the Eurostars grant, Quantib and QMENTA will be working together on the CASE project to create automatic imaging biomarker extraction and a decision support system to optimize clinical decision making for patients with ischemic or hemorrhagic stroke in the acute stage, and hence improve patient outcome.